Global Travel Media » Blog Archive Costly Covid tests stall travel revival as vax victory looms | Global Travel Media

Home » Headline News » Currently Reading:

[sam id="86" codes="true"]

Costly Covid tests stall travel revival as vax victory looms

May 11, 2021 Headline News No Comments
Huawei Black Friday Cyber Monday = Home Page

As vaccines slowly crush the coronavirus, the high cost of testing for Covid-19, which varies enormously between countries, is holding back the recovery of international air travel.

The UK recorded just one coronavirus death on Monday last week – a milestone after a year in which the death toll climbed as high as 1300 per day. The Monday statistic was an anomaly; the UK’s Covid death rate is currently running at about 20 a day. But on the same Monday (just for comparison) hundreds of Britons died of cancer, which is a normal (though sad) occurrence.

And a week later, Monday 10 May 2021 (yesterday at time of writing) the UK (England, Scotland and Northern Ireland) recorded ZERO deaths from Covid.

Vaccination is the key. More than 35 million people have been vaccinated against Covid in the UK.

International Air Transport Association (IATA) director general Willie Walsh says vaccination is critical to air travel recovery – and it should be accompanied by an easing of travel restrictions.

“We believe that as the vaccine rolls out, which is clearly having a strong impact on the suppression of transmission as evidenced by the scientific data that we’re seeing, that that should enable countries to remove some of the restrictions that they have in place.”

IATA has urged governments to ensure that high costs for Covid-19 testing don’t put travel out of reach for individuals and families. To facilitate an efficient restart of international travel, IATA argues Covid-19 testing must be affordable as well as timely, widely available and effective.

IATA says the wide variance in testing costs should raise flags among governments.

“How is it that the minimum cost of a PCR test can be as low as US$77 in Australia but US$278 in Japan, for example?” Walsh asked. Numbeo data indicates that the cost of living in Sydney and Tokyo is similar.

An IATA sampling of costs for PCR tests (the test most frequently required by governments) in 16 countries showed wide variations by markets and within markets.

Findings include:

  • Of the markets surveyed, only France complied with the World Health Organization (WHO) recommendation for the state to bear the cost of testing for travellers.
  • Of the 15 markets where there is a cost for PCR testing to the individual
    – The average minimum cost for testing was US$90.
    – The average maximum cost for testing was US$208.

Even taking the average of the low-end costs, adding PCR testing to average airfares would dramatically increase the cost of flying for individuals. Pre-crisis, the average one-way airline ticket, including taxes and charges, cost US$200 (2019 data). A US$90 PCR test raises the cost by 45% to US$290. Add another test on arrival and the one-way cost would leap by 90% to US$380. Assuming that two tests are needed in each direction, the average cost for an individual return-trip could balloon from US$400 to US$760.

The impact of the costs of COVID-19 testing on family travel would be even more severe. Based on average ticket prices (US$200) and average low-end PCR testing (US$90) twice each way, a journey for four that would have cost US$1,600 pre-COVID, could nearly double to US$3,040 – with US$1440 being testing costs.

“As travel restrictions are lifted in domestic markets, we are seeing strong demand. The same can be expected in international markets. But that could be perilously compromised by testing costs – particularly PCR testing. Raising the cost of any product will significantly stifle demand. The impact will be greatest for short-haul trips (up to 1100 km), with average fares of US$105, the tests will cost more than the flight. That’s not what you want to propose to travellers as we emerge from this crisis. Testing costs must be better managed. That’s critical if governments want to save tourism and transport jobs; avoid limiting travel freedoms to the wealthy,” Walsh said.

WHO: States Should Bear the Cost of Testing

The World Health Organisation’s International Health Regulations stipulate that states should not charge for testing or vaccination required for travel, or for the issuance of certificates. The WHO COVID Emergency Committee recently reiterated this position, calling on governments to reduce the financial burden on international travellers of complying with testing requirements and any other public health measures implemented by countries. Many states are ignoring their international treaty obligations, putting a travel recovery in jeopardy and risking millions of livelihoods. High testing costs also incentivize the market for fake certificates.

“Testing costs should not stand between people and their freedom to travel,” Walsh said.

“The best solution is for the costs to be borne by governments. It’s their responsibility under WHO guidelines. We must not let the cost of testing – particularly PCR testing – limit the freedom to travel to the rich or those able to be vaccinated. A successful restart of travel means so much to people – from personal job security to business opportunities and the need to see family and friends. Governments must act quickly to ensure that testing costs don’t stall a travel recovery.”

Among the markets surveyed, France represents the best practice. It bears the cost of testing, including tests to facilitate travel. The European Parliament is moving Europe in the right direction. Last week, it called for testing to be universal, accessible, timely and free-of-charge across the EU.

“France and the European Parliament are helping to lead the way. We are in a health and economic emergency. Testing is part of the road to recovery. So it’s a government responsibility to ensure that testing is accessible to all. If governments are not going to make testing free, at least they must ensure that there is no profiteering by testing companies at the expense of people who just want to get back to some form of normality in their life and travel habits. And that scrutiny should include governments themselves who, under no circumstances, should charge a tax for this critical service,” Walsh added.

Markets covered in the IATA sampling were Australia, Brazil, France, Germany, Indonesia, Japan, Malaysia, New Zealand, Philippines, Singapore, South Korea, Switzerland, Thailand, UK, USA, and Vietnam. Not all these markets require PCR testing. Nevertheless, the inbound requirements for PCR testing by many states make the availability of affordable options everywhere critical for a travel recovery.

Edited by Peter Needham

0 0 votes
Article Rating

Inline Feedbacks
View all comments

Comment on this Article:

Subscribe To Receive Our Daily Global Travel Media Newsletter

The FIRST Australian-based news alert is to be delivered every Morning to your Inbox before you arrive at your desk.

Sponsor / Partners

Luxury Traveller by Robert La Bua – SideBar  Position -1
Top 25 Restaurants
Travel Index



TravelManagers Tower Banner Nov





TravelManagers Tower Banner Nov





Huawei – Black Friday / Cyber Monday Sales = Tower


Huawei November Leader / Footer Banner
Global Travel Media
Would love your thoughts, please comment.x
%d bloggers like this:
Global Travel Media
Would love your thoughts, please comment.x
%d bloggers like this: